| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Caroline D. Rae | Q42420355 |
| John W Morley | Q63456465 | ||
| P2093 | author name string | J L Anderson | |
| S I Head | |||
| P433 | issue | Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4-13 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Brain function in Duchenne muscular dystrophy | |
| P478 | volume | 125 |
| Q48560958 | Abnormal distribution of GABAA receptors in brain of duchenne muscular dystrophy patients |
| Q48246615 | Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. |
| Q98224403 | Abnormalities in Brain and Muscle Microstructure and Neurochemistry of the DMD Rat Measured by in vivo Diffusion Tensor Imaging and High Resolution Localized 1H MRS |
| Q36075156 | Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS. |
| Q48181783 | Activity of Krebs cycle enzymes in mdx mice |
| Q48265187 | Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy |
| Q28084979 | Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy |
| Q37328965 | Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies |
| Q33910454 | Association of the DTNBP1 locus with schizophrenia in a U.S. population |
| Q48353071 | Automatic single-trial classification of prefrontal hemodynamic activity in an individual with Duchenne muscular dystrophy |
| Q47619099 | Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy |
| Q33846160 | Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy. |
| Q36927018 | Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. |
| Q48119931 | Central nervous system involvement in the animal model of myodystrophy. |
| Q48616988 | Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin. |
| Q47669192 | Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy |
| Q50301334 | Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy |
| Q38888495 | Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. |
| Q58571066 | Conditioned media from AICAR-treated skeletal muscle cells increases neuronal differentiation of adult neural progenitor cells |
| Q90176142 | Contribution of TRPC Channels to Intracellular Ca2 + Dyshomeostasis in Smooth Muscle From mdx Mice |
| Q91231292 | Cultured hippocampal neurons of dystrophic mdx mice respond differently from those of wild type mice to an acute treatment with corticosterone |
| Q42906825 | Decrease in prosaposin in the Dystrophic mdx mouse brain |
| Q48871109 | Decreased gray matter concentration and local synchronization of spontaneous activity in the motor cortex in Duchenne muscular dystrophy |
| Q24806537 | Deficiency in Cardiac Dystrophin Affects the Abundance of the $\alpha$ -/ $\beta$ -Dystroglycan Complex |
| Q38313622 | Delay in Diagnosis of Duchenne Muscular Dystrophy |
| Q42434322 | Delayed developmental language milestones in children with Duchenne's muscular dystrophy. |
| Q47649379 | Development of a New Self-Reporting Instrument Measuring Benefits and Side Effects of Corticosteroids in Duchenne Muscular Dystrophy: Report from a Pilot Study |
| Q37640907 | Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management |
| Q38034966 | Dissecting neural function using targeted genome engineering technologies. |
| Q47106801 | Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping |
| Q35052506 | Duchenne muscular dystrophy gene therapy: Lost in translation? |
| Q44147291 | Dysregulation of Intracellular Ca2+ in Dystrophic Cortical and Hippocampal Neurons |
| Q42512858 | Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS. |
| Q49428049 | Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype |
| Q37075463 | Dystrophin Distribution and Expression in Human and Experimental Temporal Lobe Epilepsy |
| Q91974710 | Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy |
| Q34278933 | Dystrophin and mutations: one gene, several proteins, multiple phenotypes |
| Q92756940 | Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes |
| Q45871995 | ECM-Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies |
| Q52723891 | Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons. |
| Q33614107 | Evaluation of neural damage in Duchenne muscular dystrophy patients |
| Q58125531 | Executive Skills and Academic Achievement in the Dystrophinopathies |
| Q99581504 | Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM |
| Q58122164 | Fighting the Cause of Alzheimer's and GNE Myopathy |
| Q52582834 | GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. |
| Q30479407 | GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders |
| Q33868949 | Generation of muscular dystrophy model rats with a CRISPR/Cas system |
| Q47337769 | Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies |
| Q24612644 | Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia |
| Q41522698 | Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy. |
| Q26771402 | Induced pluripotent stem cells for modeling neurological disorders |
| Q40044353 | Intellectual ability in the duchenne muscular dystrophy and dystrophin gene mutation location. |
| Q28568265 | Interaction of alpha1-syntrophin with multiple isoforms of heterotrimeric G protein alpha subunits |
| Q35944901 | Investigation of Poor Academic Achievement in Children with Duchenne Muscular Dystrophy |
| Q52143916 | Isolation and characterization of neural stem cells from dystrophic mdx mouse. |
| Q36310649 | Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy |
| Q41883614 | Lack of collagen VI promotes neurodegeneration by impairing autophagy and inducing apoptosis during aging |
| Q82345207 | Lack of dystrophin functionally affects α3β2/β4-nicotinic acethylcholine receptors in sympathetic neurons of dystrophic mdx mice |
| Q38498496 | Lack of dystrophin in mdx mice modulates the expression of genes involved in neuron survival and differentiation. |
| Q38396567 | Language disturbances in a group of participants suffering from Duchenne muscular dystrophy: a pilot study |
| Q30496655 | Loss of dystrophin and the microtubule-binding protein ELP-1 causes progressive paralysis and death of adult C. elegans |
| Q30951919 | Metabolic profiles to define the genome: can we hear the phenotypes? |
| Q34643439 | Molecular and comparative genetics of mental retardation |
| Q35566998 | Molecular substrates of potassium spatial buffering in glial cells. |
| Q41395588 | Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy |
| Q41878236 | Myoclonus dystonia and muscular dystrophy: ɛ-sarcoglycan is part of the dystrophin-associated protein complex in brain. |
| Q57292416 | Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy |
| Q35210793 | Neural integrity is maintained by dystrophin in C. elegans |
| Q30960550 | Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network |
| Q48914593 | Neuromuscular disorders associated with cerebral malformations |
| Q50310319 | Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder |
| Q46112152 | Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy |
| Q42454269 | Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system |
| Q38403023 | On the Run for Hippocampal Plasticity |
| Q36157368 | Poor facial affect recognition among boys with duchenne muscular dystrophy |
| Q36104014 | Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life? |
| Q47607013 | Proteomic Profiling of the Dystrophin-Deficient Brain. |
| Q33871052 | Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins. |
| Q64974023 | Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy. |
| Q45932123 | Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. |
| Q34209715 | Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. |
| Q98159750 | Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo |
| Q35910710 | Social behavior problems in boys with Duchenne muscular dystrophy |
| Q42916320 | Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle |
| Q63707127 | Structural Plasticity in Dendrites: Developmental Neurogenetics, Morphological Reconstructions, and Computational Modeling |
| Q55063443 | Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy. |
| Q47070321 | The RhoGAP crossveinless-c interacts with Dystrophin and is required for synaptic homeostasis at the Drosophila neuromuscular junction. |
| Q38784541 | The dystrophin Dp186 isoform regulates neurotransmitter release at a central synapse in Drosophila. |
| Q36695134 | The dystrophin gene and cognitive function in the general population |
| Q44854758 | The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia |
| Q37629726 | The roles of the dystrophin-associated glycoprotein complex at the synapse |
| Q33676836 | Truncated dystrophins can influence neuromuscular synapse structure. |
| Q34903075 | Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD). |
| Q35910726 | Verbal and memory skills in males with Duchenne muscular dystrophy |
| Q47364507 | What explains high life satisfaction in men living with Duchenne muscular dystrophy? A preliminary study to inform psychological intervention |
Search more.